Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Assets Average (2016 - 2025)

Fennec Pharmaceuticals' Assets Average history spans 15 years, with the latest figure at $59.9 million for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average rose 15.35% year-over-year to $59.9 million, compared with a TTM value of $59.9 million through Dec 2025, up 15.35%, and an annual FY2025 reading of $57.7 million, up 60.84% over the prior year.
  • Assets Average for Q4 2025 was $59.9 million at Fennec Pharmaceuticals, up from $47.1 million in the prior quarter.
  • The five-year high for Assets Average was $66.2 million in Q2 2024, with the low at $17.4 million in Q2 2022.
  • Average Assets Average over 5 years is $36.3 million, with a median of $28.7 million recorded in 2022.
  • Year-over-year, Assets Average plummeted 37.94% in 2022 and then surged 220.8% in 2024.
  • Tracing FENC's Assets Average over 5 years: stood at $27.1 million in 2021, then grew by 5.96% to $28.7 million in 2022, then dropped by 18.33% to $23.4 million in 2023, then surged by 121.74% to $51.9 million in 2024, then grew by 15.35% to $59.9 million in 2025.
  • Per Business Quant, the three most recent readings for FENC's Assets Average are $59.9 million (Q4 2025), $47.1 million (Q3 2025), and $45.6 million (Q2 2025).